Tune Therapeutics Reveals Epigenetic Editing Program…
DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Read More
Investor Login
Toggle navigation
Home
About
About Us
News & Events
For Entrepreneurs
Contact Us
Team
Portfolio
Ventures
Specialized Fund Management
About
Chiesi Ventures Fund
Asia Innovation Ventures
AgTech Initiatives
Specialized Holdings
Translational Medicine
About
Wake Forest Technology Development Program
Home
About
Team
Portfolio
News & Events
Contact
Ventures
Specialized Funds
Translational Medicine
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.
Investor Login
Investor Login
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.
